acpjournals.org/doi/10.7326/AN #MedTwitter #ObesityMedicine #GLP1 #ClinicalResearch Join the conversation
KD-J is the principal investigator of the DiViD Study, which was funded by South Eastern Norway Regional Health Authority
Popovic V, Leal A, Micic D, et al
In COPD studies, GHK-Cu at 10 nanomolar concentration restored lung fibroblasts ability to contract and restructure collagen, a function that is severely compromised in COPD patients
By purchasing, you confirm you are 21 or older and qualified researcher
Examine the cardiovascular and renal protective effects of GLP-1 receptor agonists while addressing practical considerations for implementation, including patient selection, adherence, and access challenges